Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on June 3, 2004

Arteriosclerosis, Thrombosis, and Vascular Biology. 2004
Published online before print June 3, 2004, doi: 10.1161/01.ATV.0000134297.61979.3c
A more recent version of this article appeared on August 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/8/1460    most recent
01.ATV.0000134297.61979.3cv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wientgen, H.
Right arrow Articles by Fisher, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wientgen, H.
Right arrow Articles by Fisher, E. A.

Submitted on January 15, 2004
Accepted on May 20, 2004

Subphysiologic Apolipoprotein E (ApoE) Plasma Levels Inhibit Neointimal Formation After Arterial Injury in ApoE-Deficient Mice

Hilke Wientgen ; Fayanne E. Thorngate ; Sabina Omerhodzic ; Linda Rolnitzky ; John T. Fallon ; David L. Williams ; and Edward A. Fisher *

From the Departments of Medicine (E.A.F.)/Division of Endocrinology (H.W.), and Biomathematics/Biostatistics (L.R.), and Pathology (J.T.F.), and the Zena and Michael A. Wiener Cardiovascular Institute (S.O., J.T.F., E.A.F.), Mount Sinai School of Medicine, New York, NY; the Department of Pharmacological Sciences (F.E.T., D.L.W.), State University of New York at Stony Brook, Stony Brook, NY; and the Department of Medicine, Division of Cardiology (E.A.F.), New York University School of Medicine, New York, NY.

* To whom correspondence should be addressed. E-mail: edward.fisher{at}med.nyu.edu.

Objective--Apolipoprotein E (apoE) reduces mouse atherosclerosis progression independent of plasma cholesterol level effects. A mouse artery injury model was used to examine whether apoE exhibits beneficial lipid-independent effects on neointimal formation.

Methods and Results--ApoE-deficient (apoE-/-), wild-type (WT), and transgenic apoE-/- mice (secreting apoE at different levels from adrenal glands) underwent femoral artery injury. Mice with low expression of plasma apoE (0.1% of WT) had cholesterol levels approximately half those of apoE-/- littermates (but still {approx}6x >WT). Mice with a high expression (HE; 2% to 3% of WT) of plasma apoE had cholesterol levels approximately twice those of WT. Injured WT mouse (versus apoE-/-) arteries had a smaller mean intima-to-media (I/M) ratio (0.88 versus 1.96; P<0.05). HE mice tended to have lower mean I/M ratios (1.3; P>0.05 versus apoE-/- mice). Multiple regression analysis indicated that apoE levels were significantly associated with reduced I/M ratios, but plasma cholesterol levels were not, before or after adjusting for apoE. In addition, foam cell content of the neointima and media of injured arteries, a negative prognostic indicator in postangioplasty human lesions, was inversely related to plasma apoE levels.

Conclusions--Similar to its effects on atherosclerosis progression, in a mouse model of restenosis, a subphysiological level of apoE was associated with beneficial effects on lesion size/composition.


Key words: apolipoprotein E • arterial injury • neointimal formation • restenosis • mouse




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
G. S. Getz and C. A. Reardon
Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall
J. Lipid Res., April 1, 2009; 50(Supplement): S156 - S161.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Gusarova, J. Seo, M. L. Sullivan, S. C. Watkins, J. L. Brodsky, and E. A. Fisher
Golgi-associated Maturation of Very Low Density Lipoproteins Involves Conformational Changes in Apolipoprotein B, but Is Not Dependent on Apolipoprotein E
J. Biol. Chem., July 6, 2007; 282(27): 19453 - 19462.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Z. W. Q. Moore and D. Y. Hui
Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase
J. Lipid Res., October 1, 2005; 46(10): 2083 - 2090.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Davignon
Apolipoprotein E and Atherosclerosis: Beyond Lipid Effect
Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 267 - 269.
[Full Text] [PDF]